By prohibiting the Activin A protein from functioning, researchers were able to halt the development of dyskinesia symptoms and effectively erase the brain’s ‚bad memory‘ response to L-DOPA treatments.
Scientists have discovered a new regulator — called NHR-49 — that may shed light and open potential new therapeutic avenues to prevent the formation of toxic protein clumps,…
Wir verwenden Cookies, um Ihr Erlebnis auf unserer Website zu verbessern. Durch die Nutzung unserer Website erklären Sie sich mit der Verwendung von Cookies einverstanden.
Cookie Preferences
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Name
Description
Duration
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.